Beauty Farm Medical and Health Industry Inc. disclosed a Next Day Disclosure Return detailing a share buyback executed on 5 May 2026.

• Transaction details: 60,000 ordinary shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 19.63 to HKD 20.20, with a volume-weighted average price of HKD 19.9163. Total consideration reached HKD 1.19 million.

• Impact on share capital: – Issued shares (excluding treasury shares) declined from 249.82 million to 249.76 million, a 0.024% reduction. – Treasury shares rose from 1.78 million to 1.84 million, leaving total issued shares unchanged at 251.59 million.

• Mandate utilisation: The buyback forms part of the mandate granted on 27 June 2025 authorising repurchases of up to 23.58 million shares. Cumulative buybacks under this mandate now stand at 1.84 million shares, representing 0.78% of the company’s issued shares when the mandate was approved.

• Moratorium: In line with listing rules, Beauty Farm is restricted from issuing new shares or selling treasury shares until 4 June 2026.